Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Cartesian Therapeutics, Inc. | 58,820 | reported | 06 Jan 2026 | tx 18+1,573,293.87−118,018.87 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 06 Jan 2026 | SALE | Cartesian Therapeutics, Inc. | 3,573 | 6.82 USD | |
| 02 Jan 2026 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 27,000 | 0.00 USD | |
| 02 Jan 2026 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 77,000 | 0.00 USD | deriv |
| 03 Jan 2025 | SALE | Cartesian Therapeutics, Inc. | 932 | 16.72 USD | |
| 06 Jan 2025 | SALE | Cartesian Therapeutics, Inc. | 948 | 16.83 USD | |
| 02 Jan 2025 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 19,000 | 0.00 USD | |
| 02 Jan 2025 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 56,000 | 0.00 USD | deriv |
| 14 Nov 2024 | SALE | Cartesian Therapeutics, Inc. | 35,000 | 16.13 USD | |
| 14 Nov 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 35,000 | 3.23 USD | |
| 15 Nov 2024 | SALE | Cartesian Therapeutics, Inc. | 20,000 | 17.14 USD | |
| 15 Nov 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 20,000 | 3.23 USD | |
| 14 Nov 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 35,000 | — | deriv |
| 15 Nov 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 20,000 | — | deriv |
| 08 Apr 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 2,565.87 | — | deriv |
| 08 Apr 2024 | EXERCISE | Cartesian Therapeutics, Inc. | 85,528 | — | deriv |
| 02 Jan 2024 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 548,200 | 0.00 USD | |
| 02 Jan 2024 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 703,000 | 0.00 USD | deriv |
| 13 Nov 2023 | GRANT_AWARD | Cartesian Therapeutics, Inc. | 2,565.87 | — | deriv |